Toxoplasmosis medical therapy

Jump to navigation Jump to search

Toxoplasmosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxoplasmosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Toxoplasmosis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxoplasmosis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxoplasmosis medical therapy

CDC on Toxoplasmosis medical therapy

Toxoplasmosis medical therapy in the news

Blogs on Toxoplasmosis medical therapy

Directions to Hospitals Treating Toxoplasmosis

Risk calculators and risk factors for Toxoplasmosis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Medical Therapy

Teatment is not needed for a healthy person who is not pregnant. Symptoms will usually go away within a few weeks. Treatment may be recommended for pregnant women or persons who have weakened immune systems [1].

Pharmacotherapy

Medications that are prescribed for acute Toxoplasmosis are:

(Other antibiotics such as minocycline have seen some use as a salvage therapy).

Medications that are prescribed for latent Toxoplasmosis are:

  • atovaquone — an antibiotic that has been used to kill Toxoplasma cysts in situ in AIDS patients. [2]
  • clindamycin — an antibiotic which, in combination with atovaquone, seemed to optimally kill cysts in mice.[3]

However, in latent infections successful treatment is not guaranteed, and some subspecies exhibit resistance.

References

  1. http://www.dpd.cdc.gov/dpdx/HTML/Toxoplasmosis.htm
  2. "Toxoplasmosis - treatment key research". NAM & aidsmap. 2005-11-02.
  3. Djurković-Djaković O, Milenković V, Nikolić A, Bobić B, Grujić J (2002). "Efficacy of atovaquone combined with clindamycin against murine infection with a cystogenic (Me49) strain of Toxoplasma gondii" (PDF). J Antimicrob Chemother. 50 (6): 981–7. doi:10.1093/jac/dkf251. PMID 12461021.


Template:WikiDoc Sources